Form 4: Iris Parent Holding Insider Reports Stock Transaction
Insider Transaction (Form 4)
Valetudo Therapeutics LLC and 1 other reported changes in beneficial ownership of Iris Parent Holding Corp. common stock on July 2, 2026.
Summary
- Other acquisition/disposition: acquired 3,448,926 Common Stock, par value $0.0001 per share on July 2, 2026; holds 5,244,351 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Valetudo Therapeutics LLC — 10% owner
Chris Kim — Director, Officer (Chief Executive Officer), 10% owner
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-02 | Other acquisition/disposition | Common Stock, par value $0.0001 per share | 3,448,926 | — | — | 5,244,351 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-02 | Other acquisition/disposition (3,448,926 shares) |
Keywords
insider transaction, Form 4, LIMN, Liminatus Pharma, Inc., neutral, Valetudo Therapeutics LLC, Chris Kim
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.